Recommendations for the Management of Drug-Drug Interactions Between the COVID-19 Antiviral Nirmatrelvir/Ritonavir (Paxlovid) and Comedications. (2022)

First Author: Marzolini C

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1002/cpt.2646

PubMed Identifier: 35567754

Publication URI: http://europepmc.org/abstract/MED/35567754

Type: Journal Article/Review

Volume: 112

Parent Publication: Clinical pharmacology and therapeutics

Issue: 6

ISSN: 0009-9236